14:00
|
Welcome and Introduction
-
Manjit Dosanjh
(CERN) Prof.
Pawel Olko
(Institute of Nuclear Physics PAN)
()
|
14:30
|
Report from a meeting of European´s particle therapy center in Brussels and strategic consideration on evaluation and further development of particle therapy in Europe.
- Prof.
Michael Baumann
(Dept. of Radiation Oncology at the University Hospital of Dresden)
()
|
15:00
|
Status of research and clinical trials at MIT and HIT
- Prof.
Juergen Debus
(HIT)
()
|
15:30
|
The status of CNAO and clinical trials at CNAO.
- Prof.
Roberto Orecchia
(CNAO)
()
|
16:30
|
The status of clinical trials in particle therapy in the USA.
- Prof.
Bhadrasain Vikram
(National Cancer Institute)
()
|
17:00
|
The Status of MedAustron and clinical trials for particle therapy
- Prof.
Richard Poetter
(Medical University of Vienna) Prof.
Georg Dietmar
(Medical University of Vienna) Dr
Thomas Schreiner
(PEG MedAustron)
()
|
17:30
|
Molecular tumour response to accelerated ions in Sweden and role of cellular modifying factors.
- Dr
Rolf Lewenshon
(Karolinska Institutet Radio Oncologist)
()
|